BEAM
#1665
Beam Therapeutics Inc. - Common Stock
30.7 0 USD
-0.01%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.62%
Variación mensual
-1.35%
Variación en los últimos 6 meses
-4.00%
Cambio anual
+55.36%
Cierres anteriores
30.8 9
Open
30.7 7
Mínimo
30.2 2
High
30.8 5
Volumen
385
Financials
- Market Capitalization 3.16 B
- Employee 522
- Founded 2017
- CEO John Evans
- Website www.beamtx.com
- Headquarter Delaware, United States
- FIGI BBG00KXC8646
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-48.63
Relación precio/flujo de caja
14.54
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1629 |  ARQT Arcutis Biotherapeutics, Inc. - Common stock | 27.09 USD | +1.04% | -2.38% | +5.53% | +74.21% | 3.39 B USD | ||
| 1657 |  IDYA IDEAYA Biosciences, Inc. - Common Stock | 36.60 USD | -0.14% | -7.90% | +21.03% | +12.34% | 3.22 B USD | ||
| 1672 |  RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 31.09 USD | -2.93% | -12.72% | +21.73% | +13.51% | 3.06 B USD | ||
| 1673 |  ELVN Enliven Therapeutics, Inc. - Common Stock | 51.75 USD | +0.04% | +2.31% | +21.74% | +150.48% | 3.15 B USD |